piperacillin has been researched along with Campylobacter Infection in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andukuri, VG; Iguidbashian, JP; Kukrety, S; Parekh, JD | 1 |
| Arias, MJ; de la Torre, A; Díaz, JA; Hernández, AP; Silva, E | 1 |
| Anstead, G; Blaser, M; Craig, F; Jorgensen, J; Patterson, T | 1 |
3 other study(ies) available for piperacillin and Campylobacter Infection
| Article | Year |
|---|---|
Topics: Aged; Anti-Bacterial Agents; Azithromycin; Campylobacter Infections; Coinfection; Colitis, Ulcerative; Feces; Female; Fever; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas Infections; Sigmoidoscopy; Treatment Outcome | 2018 |
Comparative in vitro study of the antimicrobial activities of different commercial antibiotic products for intravenous administration.
Topics: Animals; Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; Campylobacter Infections; Drug Resistance; Drug Resistance, Multiple, Bacterial; Humans; Infusions, Intravenous; Injections, Intravenous; Meropenem; Mice; Mice, Inbred BALB C; Penicillanic Acid; Piperacillin; Tazobactam; Thienamycins; Tissue Distribution | 2010 |
Thermophilic multidrug-resistant Campylobacter fetus infection with hypersplenism and histiocytic phagocytosis in a patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Campylobacter fetus; Campylobacter Infections; Ceftazidime; Cephalosporins; Diarrhea; Drug Resistance, Microbial; Enzyme Inhibitors; Erythromycin; Histiocytes; Histiocytosis; Humans; Hypersplenism; Male; Penicillanic Acid; Penicillins; Phagocytosis; Piperacillin; Quinolones; Splenic Infarction; Splenomegaly; Tazobactam | 2001 |